American Society of Hematology

SHERPA: Blue

People

  1. Zelenetz
    Zelenetz
  2. Palomba
    Palomba
  3. Horwitz
    Horwitz
  4. Hamlin
    Hamlin
  5. Noy
    Noy
  6. Moskowitz
    Moskowitz
  7. Kumar
    Kumar
  8. Seshan
    Seshan
  9. Caron
    Caron
  10. Dogan
    Dogan

Groups

  1. Center for Hematologic Malignancies (98)
  2. Department of Medicine (98)
  3. Executive Committee, Center for Hematologic Malignancies (98)
  4. Hematologic Malignancies, Division of (98)
  5. Lymphoma (98)
  6. Survivorship Research (37)
  7. Epidemiology and Biostatistics (36)
  8. Population Sciences Research Program (35)
  9. Biostatistics Service (30)
  10. Sloan Kettering Institute Postdocs (28)
Search Within
  1. "Anas Younes"
Formats
  1. Meeting Abstract (76)
  2. Journal Article (22)
Groups
  1. Center for Hematologic Malignancies (98)
  2. Department of Medicine (98)
  3. Executive Committee, Center for Hematologic Malignancies (98)
  4. Hematologic Malignancies, Division of (98)
  5. Lymphoma (98)
  6. Survivorship Research (37)

More Groups

People
  1. Anas Younes (98)
  2. Andrew Zelenetz (42)
  3. Maria Palomba (37)
  4. David Straus (36)
  5. Matthew Matasar (36)
  6. Paul Hamlin (34)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (6)
  4. 2020 (8)
  5. 2019 (17)
  6. 2018 (9)

More Years

Publications
  1. Blood (90)
  2. Blood Advances (7)
  3. Hematology-American Society of Hematology Education Program (1)

Results (98)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
    Journal Article

    Younes, A.; Burke, J. M.; Cheson, B. D.; Diefenbach, C. S.; Ferrari, S.; Hahn, U. H.; Hawkes, E. A.; Khan, C.; Lossos, I. S.; Musuraca, G.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPĪ± checkpoint blocker
    Journal Article

    Dacek, M. M.; Kurtz, K. G.; Wallisch, P.; Pierre, S. A.; Khayat, S.; Bourne, C. M.; Gardner, T. J.; Vogt, K. C.; Aquino, N.; Younes, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing
    Meeting Abstract

    Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
    Journal Article

    Younes, A.; Burke, J. M.; Diefenbach, C.; Ferrari, S.; Khan, C.; Sharman, J. P.; Tani, M.; Ujjani, C.; Vitolo, U.; Yuen, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
    Journal Article

    Qualls, D.; Lam, H. Y.; Whiting, K.; Kumar, A.; Matasar, M.; Owens, C.; Nichols, C.; Espeleta, J. A.; Qiu, A.; Subzwari, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • TP53 mutations and RNA binding protein MUSASHI 2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Meeting Abstract

    Erazo, I. T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Barbash, O.; Refermat, A. Y.; Batlevi, C. L.; Younes, A.; Kharas, M. G.
    Blood (2021)

    Fulltext@MSK | Save
  • PK and PD assessment of BET inhibitor pelabresib (CPI-0610) in patients with relapsed or refractory lymphoma: Findings from a phase 1 study
    Meeting Abstract

    Blum, K. A.; Supko, J. G.; Maris, M.; Flinn, I. W.; Goy, A. H.; Younes, A.; Bobba, S.; Senderowicz, A.; Efuni, S.; Rippley, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition
    Journal Article

    Bala Tannan, N.; Manzari, M. T.; Herviou, L.; Da Silva Ferreira, M.; Hagen, C.; Kiguchi, H.; Manova-Todorova, K.; Seshan, V.; de Stanchina, E.; Heller, D. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Joffe, E.; Leyfman, Y.; Drill, E.; Rajeeve, S.; Zelenetz, A. D.; Lia Palomba, M.; Moskowitz, C. H.; Portlock, C.; Noy, A.; Horwitz, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save